Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1

Interventions

Specimen Handling 69Magnetic Resonance Spectroscopy 52Biopsy 42pembrolizumab 26Carboplatin 26Cyclophosphamide 25Radiation 24Radiotherapy 23Nivolumab 23Cisplatin 21Paclitaxel 20olaparib 18Etoposide 18Doxorubicin 18Vincristine 17Dexamethasone 17X-Rays 16Immunoglobulin G 15Disulfides 15Cytarabine 15Taxes 14Prednisone 14Platinum 14Leucovorin 14Bevacizumab 141,2-diaminocyclohexaneplatinum II citrate 14durvalumab 13Radiotherapy, Intensity-Modulated 12Ipilimumab 12atezolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Diagnostic Imaging × 30 days × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡